Cargando…

Expanded validation of the effect and quality of a pathogen inactivation system based on riboflavin photochemistry on platelet bacterial contamination

BACKGROUND: Bacterial contamination still poses serious challenges to blood safety. Platelets have the highest bacterial contamination risk of all blood components. METHODS: Twenty units of manual platelets were prepared from blood donated by our hospital, which were inoculated with Staphylococcus a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Bin, Yi, Meng, Yang, Guang, Yang, Lu, Shang, Wei, Liu, Yi, Zhong, Xiaolong, Zhu, Liguo, Wang, Deqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743726/
https://www.ncbi.nlm.nih.gov/pubmed/35071430
http://dx.doi.org/10.21037/atm-21-5834
Descripción
Sumario:BACKGROUND: Bacterial contamination still poses serious challenges to blood safety. Platelets have the highest bacterial contamination risk of all blood components. METHODS: Twenty units of manual platelets were prepared from blood donated by our hospital, which were inoculated with Staphylococcus aureus and Escherichia coli suspensions. The riboflavin sodium phosphate solution was added into platelets, adjusted to a final concentration of 160 μmol/L. Platelets added into an illumination bag and placed in the inactivation system for riboflavin photochemistry at various doses. The inactivation effect of bacteria was evaluated on a Columbia blood agar plate by the plate counting method. Meanwhile, the blood routine, blood gas analysis, platelet aggregation test, and thromboelastogram of platelets before and after treatment were detected to evaluate the changes of platelet quality after treatment. RESULTS: the inactivation effect of S. aureus and E. coli at the inactivation dose (16.9 J/cm(2)) could reach more than 4 logs. After treatment at 16.9 J/cm(2), the blood routine results showed that the platelet count was significantly different (P<0.05), and the blood gas analysis showed that the oxygen partial pressure (pO(2)) and lactic acid concentration (cLac) were also significantly different (P<0.05). After 16.9 J/cm(2) treatment, there was a significant difference between Arachidonic acid (AA) and Collagen (Cog) activator groups in the platelet aggregation experiment (P<0.05), but there was no significant difference in the main thrombelastogram (TEG) parameters (R value, K value, angle value, MA value) after treatment (P>0.05). CONCLUSIONS: The inactivation effect of this set of blood component pathogen inactivation system on platelet bacterial contamination could be considered to meet actual clinical needs, with the inactivation treatment having little impact on platelet function.